NOD.129P2(B6)-Nos2tm1Lau/Ieg
Status | Available to order |
EMMA ID | EM:09914 |
International strain name | NOD.129P2(B6)-Nos2tm1Lau/Ieg |
Alternative name | NOD.B6;129P2-Nos2>tm1Lau |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Nos2tm1Lau |
Gene/Transgene symbol | Nos2 |
Information from provider
Provider | Volker Burkart |
Provider affiliation | Institut für Klinische Diabetologie, Deutsches-Diabetes-Zentrum |
Genetic information | Replacement of exons 12 and 13 encoding the calmodulin-binding domain of the iNOS (Nos2) gene by a neomycin cassette. |
Phenotypic information | Homozygous:After backcross on the NOD background no homozygous offspring was obtained anymore.Heterozygous:Heterozygous mice are viable and fertile and show no apparent abnormalities. No further characterization was performed. |
Breeding history | B6;129P2-Nos2tm1Lau mice, provided by Paula Sherman, were backcrossed for 32 generations on the NOD/Lt background. For the last 9 generations intercross of heterozygous mice was performed. |
References |
|
Homozygous fertile | no |
Homozygous viable | no |
Homozygous matings required | no |
Immunocompromised | not known |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | heterozygous NOD |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (allele matching)
- abnormal sleep pattern / MGI
- abnormal inflammatory response / MGI
- decreased inflammatory response / MGI
- abnormal surfactant physiology / MGI
- abnormal brain wave pattern / MGI
- abnormal circadian sleep/wake cycle / MGI
- decreased circulating alanine transaminase level / MGI
- decreased susceptibility to injury / MGI
- decreased circulating aspartate transaminase level / MGI
- immune system phenotype / MGI
- abnormal systemic arterial blood pressure / MGI
- abnormal immune system morphology / MGI
- abnormal testis morphology / MGI
- decreased white adipose tissue amount / MGI
- abnormal gametogenesis / MGI
- abnormal reproductive system morphology / MGI
- altered tumor susceptibility / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal adaptive immunity / MGI
- abnormal sperm number / MGI
- increased growth rate / MGI
- increased insulin sensitivity / MGI
- increased testis weight / MGI
- skin inflammation / MGI
- abnormal male meiosis / MGI
- improved glucose tolerance / MGI
- abnormal enzyme/coenzyme level / MGI
- increased T cell proliferation / MGI
- homeostasis/metabolism phenotype / MGI
- cardiovascular system phenotype / MGI
- abnormal fertilization / MGI
- increased circulating creatinine level / MGI
- increased circulating antidiuretic hormone level / MGI
- decreased circulating leptin level / MGI
- enlarged seminiferous tubules / MGI
- increased single-positive T cell number / MGI
- enlarged inguinal lymph nodes / MGI
- abnormal blood homeostasis / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- increased food intake / MGI
- increased urine pH / MGI
- abnormal heart morphology / MGI
- abnormal corpus callosum morphology / MGI
- abnormal eating behavior / MGI
- abnormal glucose homeostasis / MGI
- abnormal respiratory system physiology / MGI
- abnormal blood coagulation / MGI
- enhanced wound healing / MGI
- abnormal bone mineralization / MGI
- increased susceptibility to pharmacologically induced seizures / MGI
- abnormal frequency of paradoxical sleep / MGI
- decreased susceptibility to induced choroidal neovascularization / MGI
- abnormal physiological neovascularization / MGI
- abnormal bone structure / MGI
- increased left ventricle developed pressure / MGI
- increased mortality induced by ionizing radiation / MGI
- abnormal respiratory bronchiole morphology / MGI
- abnormal osteoclast morphology / MGI
- abnormal heart ventricle morphology / MGI
- abnormal myocardium layer morphology / MGI
- respiratory system phenotype / MGI
- abnormal platelet physiology / MGI
- decreased systemic arterial systolic blood pressure / MGI
- decreased susceptibility to induced colitis / MGI
- decreased oligodendrocyte number / MGI
- mortality/aging / MGI
- improved central nervous system regeneration / MGI
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- abnormal trabecular bone morphology / MGI
- abnormal circulating glucose level / MGI
- abnormal circulating serum albumin level / MGI
- abnormal systemic arterial blood pressure / MGI
- abnormal heart morphology / MGI
- decreased digestive secretion / MGI
- abnormal immune system morphology / MGI
- abnormal corpus callosum morphology / MGI
- abnormal uterus morphology / MGI
- abnormal testis morphology / MGI
- increased body weight / MGI
- abnormal eating behavior / MGI
- abnormal sleep pattern / MGI
- abnormal osteoclast physiology / MGI
- abnormal cardiovascular system physiology / MGI
- increased circulating triglyceride level / MGI
- abnormal digestion / MGI
- abnormal homeostasis / MGI
- decreased white adipose tissue amount / MGI
- abnormal immune system physiology / MGI
- abnormal inflammatory response / MGI
- increased inflammatory response / MGI
- pancreas inflammation / MGI
- decreased inflammatory response / MGI
- abnormal mammary gland physiology / MGI
- abnormal gametogenesis / MGI
- decreased litter size / MGI
- abnormal motor capabilities/coordination/movement / MGI
- abnormal sensory capabilities/reflexes/nociception / MGI
- abnormal glucose homeostasis / MGI
- premature death / MGI
- abnormal cardiovascular system morphology / MGI
- abnormal blood circulation / MGI
- abnormal respiratory system physiology / MGI
- abnormal reproductive system morphology / MGI
- altered tumor susceptibility / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal adaptive immunity / MGI
- abnormal macrophage physiology / MGI
- abnormal blood coagulation / MGI
- abnormal eosinophil cell number / MGI
- abnormal vitreous body morphology / MGI
- enhanced wound healing / MGI
- abnormal thermal nociception / MGI
- increased systemic arterial blood pressure / MGI
- increased growth rate / MGI
- increased insulin sensitivity / MGI
- abnormal bone mineralization / MGI
- increased susceptibility to pharmacologically induced seizures / MGI
- delayed wound healing / MGI
- decreased circulating alanine transaminase level / MGI
- abnormal bone healing / MGI
- increased myocardial infarction size / MGI
- allodynia / MGI
- abnormal frequency of paradoxical sleep / MGI
- neuron degeneration / MGI
- liver fibrosis / MGI
- decreased susceptibility to induced choroidal neovascularization / MGI
- nervous system phenotype / MGI
- abnormal physiological neovascularization / MGI
- abnormal bone structure / MGI
- increased left ventricle developed pressure / MGI
- abnormal tooth hard tissue morphology / MGI
- abnormal hormone level / MGI
- abnormal adrenocorticotropin level / MGI
- increased mortality induced by ionizing radiation / MGI
- abnormal uterine artery morphology / MGI
- decreased susceptibility to kidney reperfusion injury / MGI
- abnormal peripheral nervous system regeneration / MGI
- abnormal respiratory bronchiole morphology / MGI
- increased length of allograft survival / MGI
- abnormal surfactant physiology / MGI
- increased susceptibility to experimental autoimmune encephalomyelitis / MGI
- increased testis weight / MGI
- increased mean systemic arterial blood pressure / MGI
- decreased adiponectin level / MGI
- skin inflammation / MGI
- abnormal osteoclast morphology / MGI
- decreased osteoclast cell number / MGI
- abnormal brain wave pattern / MGI
- decreased eosinophil cell number / MGI
- abnormal response to infection / MGI
- increased susceptibility to parasitic infection / MGI
- increased circulating prolactin level / MGI
- decreased susceptibility to injury / MGI
- abnormal male meiosis / MGI
- increased circulating cholesterol level / MGI
- abnormal circulating estradiol level / MGI
- improved glucose tolerance / MGI
- abnormal heart ventricle morphology / MGI
- abnormal response to tactile stimuli / MGI
- abnormal enzyme/coenzyme level / MGI
- abnormal myocardium layer morphology / MGI
- atherosclerotic lesions / MGI
- increased T cell proliferation / MGI
- homeostasis/metabolism phenotype / MGI
- cardiovascular system phenotype / MGI
- immune system phenotype / MGI
- respiratory system phenotype / MGI
- reproductive system phenotype / MGI
- abnormal fertilization / MGI
- abnormal platelet physiology / MGI
- abnormal T-helper 1 physiology / MGI
- increased circulating creatinine level / MGI
- increased renin activity / MGI
- increased circulating antidiuretic hormone level / MGI
- decreased circulating aspartate transaminase level / MGI
- decreased circulating leptin level / MGI
- decreased cerebral infarction size / MGI
- increased systemic arterial systolic blood pressure / MGI
- decreased systemic arterial systolic blood pressure / MGI
- abnormal involution of the mammary gland / MGI
- enlarged seminiferous tubules / MGI
- increased single-positive T cell number / MGI
- abnormal osteoclast differentiation / MGI
- increased IgG2a level / MGI
- decreased susceptibility to induced colitis / MGI
- increased interferon-gamma secretion / MGI
- decreased susceptibility to endotoxin shock / MGI
- decreased survivor rate / MGI
- prolonged diestrus / MGI
- increased urine pH / MGI
- abnormal platelet aggregation / MGI
- enlarged inguinal lymph nodes / MGI
- abnormal blood homeostasis / MGI
- abnormal induced retinal neovascularization / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- decreased oligodendrocyte number / MGI
- abnormal heart right ventricle pressure / MGI
- mortality/aging / MGI
- increased bone volume / MGI
- increased compact bone mass / MGI
- decreased urine prostaglandin level / MGI
- increased food intake / MGI
- hyperlactation / MGI
- abnormal circadian sleep/wake cycle / MGI
- improved central nervous system regeneration / MGI
- increased sperm number / MGI
Literature references
- Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.;Laubach V E, Shesely E G, Smithies O, Sherman P A, ;1995;Proceedings of the National Academy of Sciences of the United States of America;92;10688-92; 7479866
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).